These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3498916)
1. Central hypothermic effects of some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium ion (MPP+). Satoh N; Yonezawa A; Tadano T; Kisara K; Arai Y; Kinemuchi H Neurosci Lett; 1987 Sep; 80(1):100-5. PubMed ID: 3498916 [TBL] [Abstract][Full Text] [Related]
2. Acute effects of a parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mouse body temperature. Satoh N; Yonezawa A; Tadano T; Kisara K; Arai Y; Kinemuchi H Life Sci; 1987 Sep; 41(11):1415-24. PubMed ID: 3498107 [TBL] [Abstract][Full Text] [Related]
3. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl. Fuller RW; Hemrick-Luecke SK Life Sci; 1986 Nov; 39(18):1645-50. PubMed ID: 3095601 [TBL] [Abstract][Full Text] [Related]
4. Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates. RĂos C; Tapia R Neurosci Lett; 1987 Jun; 77(3):321-6. PubMed ID: 3497366 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of rat brain monoamine oxidase by some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion. Arai Y; Kinemuchi H; Hamamichi N; Satoh N; Tadano T; Kisara K Neurosci Lett; 1986 May; 66(1):43-8. PubMed ID: 3487053 [TBL] [Abstract][Full Text] [Related]
7. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Fuller RW; Hemrick-Luecke SK; Perry KW J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609 [TBL] [Abstract][Full Text] [Related]
8. Behavioral and biochemical changes following acute administration of MPTP and MPP+. Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017 [TBL] [Abstract][Full Text] [Related]
9. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse. Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525 [TBL] [Abstract][Full Text] [Related]
10. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. Mizuno Y; Sone N; Saitoh T J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573 [TBL] [Abstract][Full Text] [Related]
11. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
12. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat. Algeri S; Ambrosio S; Garofalo P; Gerli P Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067 [TBL] [Abstract][Full Text] [Related]
14. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats. Chang GD; Ramirez VD Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041 [TBL] [Abstract][Full Text] [Related]
15. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety. Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166 [TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons. Sanchez-Ramos J; Barrett JN; Goldstein M; Weiner WJ; Hefti F Neurosci Lett; 1986 Dec; 72(2):215-20. PubMed ID: 2880321 [TBL] [Abstract][Full Text] [Related]
17. Time-dependent inhibition of rat brain monoamine oxidase by an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine. Arai Y; Hamamichi N; Kinemuchi H Neurosci Lett; 1986 Oct; 70(2):255-60. PubMed ID: 3490636 [TBL] [Abstract][Full Text] [Related]
18. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium. Vyas I; Heikkila RE; Nicklas WJ J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701 [TBL] [Abstract][Full Text] [Related]
19. Quantification of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion in brain tissue by gas chromatography/mass spectrometry. Shih MC; Markey SP Biomed Environ Mass Spectrom; 1986 Feb; 13(2):85-9. PubMed ID: 2937483 [TBL] [Abstract][Full Text] [Related]
20. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity. Irwin I; Langston JW; DeLanney LE Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]